KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Newmont (NEM) Capital Expenditures (2016 - 2025)

Newmont (NEM) has 13 years of Capital Expenditures data on record, last reported at $808.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 7.66% year-over-year to $808.0 million; the TTM value through Dec 2025 reached $3.0 billion, down 10.79%, while the annual FY2025 figure was $3.0 billion, 10.79% down from the prior year.
  • Capital Expenditures reached $808.0 million in Q4 2025 per NEM's latest filing, up from $727.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $920.0 million in Q4 2023 and bottomed at $398.0 million in Q3 2021.
  • Average Capital Expenditures over 5 years is $644.4 million, with a median of $631.0 million recorded in 2022.
  • Peak YoY movement for Capital Expenditures: skyrocketed 61.6% in 2024, then dropped 17.1% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $441.0 million in 2021, then soared by 46.49% to $646.0 million in 2022, then soared by 42.41% to $920.0 million in 2023, then dropped by 4.89% to $875.0 million in 2024, then decreased by 7.66% to $808.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $808.0 million in Q4 2025, $727.0 million in Q3 2025, and $674.0 million in Q2 2025.